Legend Biotech: Barclays cuts target price to $78 from $80
LEGN•Related News
Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
XLO•
Cypherpunk Technologies swings to Q2 profit on Zcash gains
CYPH•
Ituran declares USD 0.5 per share Q2 dividend, totaling USD 10 million
ITRN•
Bio-Techne beats revenue estimates on research, diagnostics demand uptick
TECH•
Milestone Pharmaceuticals Q2 FY26 net loss widens 120.7% to $28.61 million
MIST•